Lawrence Otto Klein's Net Worth
$26.9 Million
Who is Lawrence Otto Klein?
Lawrence Otto Klein has an estimated net worth of $26.9 Million. This is based on reported shares across multiple companies, which include Dyne Therapeutics, Inc., CRISPR Therapeutics AG, Jasper Therapeutics, Inc., and Oruka Therapeutics, Inc..
SEC CIK
Lawrence Otto Klein's CIK is 0001762583
Past Insider Trading and Trends
2021 was Lawrence Otto Klein's most active year for acquiring shares with 17 total transactions. Lawrence Otto Klein's most active month to acquire stocks was the month of February. 2021 was Lawrence Otto Klein's most active year for disposing of shares, totalling 28 transactions. Lawrence Otto Klein's most active month to dispose stocks was the month of December. 2021 saw Lawrence Otto Klein paying a total of $3,750,475.16 for 275,991 shares, this is the most they've acquired in one year. In 2021 Lawrence Otto Klein cashed out on 274,925 shares for a total of $21,158,497.34, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Dyne Therapeutics, Inc. (DYN) Snapshot price: $33.03
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
|
∞
| 10.72K |
—
|
—
| 10.72K |
Jul 31 - Sep 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
CRISPR Therapeutics AG (CRSP) Snapshot price: $44.9
CBO & COO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 16
| |||
Form 4
| +20.03% | 4.47K |
$61.98 | -$192,867.80 | 26.8K |
Mar 10 - Mar 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 18
| |||
Form 4
| +226.25% | 15.48K |
$69.17 | -$773,666.45 | 22.32K |
Dec 3 - Dec 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 15
| |||
Form 4
| +551.71% | 5.79K |
$117.86 | -$495,837.02 | 6.84K |
Sep 10 - Sep 13
| |||
Form 4
| -91.95% | -12.00K |
$82.04 | -$9,635,240.00 | 1.05K |
Scheduled
|
Mar 23
| ||
Form 4
| +23.02% | 2.44K |
$124.15 | -$265,805.15 | 13.05K |
Mar 10 - Mar 11
| |||
Form 4/A
| +153.98% | 16.33K |
$14.43 | $235,699.62 | 26.94K |
Jan 15
| |||
Form 4
| +0.03% | 10 |
$114.09 | -$5,035,164.06 | 40K |
Scheduled
|
Jan 15
| ||
Form 4
| -46.96% | -9.39K |
$153.11 | -$1,438,009.12 | 10.61K |
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 5
| |||
Form 4
|
—
|
0
|
$42.37 | -$4,691,112.98 | 20K |
Scheduled
|
Jun 24 - Jun 25
| ||
Form 4
|
—
|
0
|
$33.13 | -$1,363,470.58 | 20K |
Scheduled
|
May 11
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 10
| |||
Form 4
|
—
|
0
|
$27.94 | -$883,152.84 | 20K |
Scheduled
|
Jul 10 - Jul 11
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 5
| |||
Form 4
|
∞
| 20K |
$29.87 | $597,400.00 | 20K |
Jan 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Jasper Therapeutics, Inc. (JSPR) Snapshot price: $18.63
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
∞
| 24.5K |
—
|
—
| 24.5K |
Oct 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Oruka Therapeutics, Inc. (ABIO) Snapshot price: $2.48
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |